Artificial Intelligence (AI)-Driven Medical Device Vigilance Platform Market Expected To Reach $5.61 Billion By 2030 As Growth Accelerates At 22.6% CAGR
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Artificial Intelligence (AI)-Driven Medical Device Vigilance Platform Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
The market for AI-powered vigilance platforms within the medical device sector has experienced remarkable expansion, projecting a rise from \$2.02 billion in 2025 to \$2.48 billion in 2026, demonstrating a compound annual growth rate of 22.9%. This significant upward trend in the historical period has been fueled by several key factors, including a greater uptake of medical devices, the broadening scope of post-market surveillance mandates, a continuous increase in the intricacy of device offerings, the burgeoning volume of adverse event reporting databases, and the initial integration of data analytics into vigilance processes.
The market for artificial intelligence-powered vigilance platforms in the medical device sector is poised for significant expansion, projected to reach $5.61 billion by 2030 with a compound annual growth rate of 22.6%. This predicted surge is fueled by several key factors, including heightened regulatory oversight regarding device safety, a greater need for continuous risk assessment, the increasing prevalence of cloud-based vigilance solutions, deeper integration with hospital device data streams, and a broader adoption of AI for compliance. During this forecast period, prominent trends will include a greater embrace of AI for identifying potential device issues, increased utilization of predictive analytics to ensure device safety, tighter integration of real-time vigilance systems, the expansion of automated processes for regulatory reporting, and a stronger emphasis on managing risks before they escalate.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28912&type=smp
Artificial Intelligence (AI)-Driven Medical Device Vigilance Platform Market Development Factors: Which Trends Are Supporting Demand?
Anticipated increases in healthcare spending are poised to significantly boost the market for artificial intelligence (AI) powered medical device vigilance platforms. This elevated healthcare expenditure, encompassing outlays by individuals, organizations, and governments for health maintenance and enhancement, is escalating due to the rising incidence of chronic conditions necessitating ongoing medical attention, lengthy treatment plans, and extensive management resources. Such increased financial commitment from the healthcare sector empowers hospitals and providers to deploy robust safety and oversight systems, facilitating adherence to regulatory mandates and bolstering patient protection. As an illustration, the UK’s Office for National Statistics indicated in April 2025 that government contributions to healthcare spending in the UK represented the majority, reaching $344 billion (£258 billion) in 2024, a real-term increase of 2.5% compared to the previous year. Consequently, the upward trend in healthcare expenditure is a key factor driving the expansion of the AI-driven medical device vigilance platform market.
The burgeoning field of clinical research is identified as a significant catalyst for the advancement of the artificial intelligence (AI)-driven medical device vigilance platform market. This growth in clinical research encompasses an increasing number of studies, research facilities, and resources dedicated to expanding medical understanding and enhancing patient well-being. Such expansion is fueled by escalating investments from both public and private sectors, which in turn amplifies the capability to undertake more trials, optimize research methodologies, and broaden access to novel therapeutic options. The expansion of clinical research validates the adoption of AI-driven medical device vigilance platforms by equipping healthcare entities and research organizations with the requisite infrastructure and financial backing to implement thorough monitoring protocols, guarantee adherence to regulatory frameworks, and elevate patient safety standards. A pertinent example is the UK government’s December 2024 pledge of $134 million (£100 million) to establish 20 new commercial research delivery centers throughout the United Kingdom, a strategic initiative designed to improve patient access to clinical trials and expedite research approvals. Therefore, the expanding landscape of clinical research is unequivocally driving the growth trajectory of the artificial intelligence (AI)-driven medical device vigilance platform market.
Artificial Intelligence (AI)-Driven Medical Device Vigilance Platform Market Segments: Where Are The Largest Growth Opportunities?
The artificial intelligence (AI)-driven medical device vigilance platform market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Adverse Event Detection, Regulatory Compliance, Risk Management, Data Analytics, Other Applications
4) By End-User: Hospitals, Medical Device Manufacturers, Regulatory Agencies, Contract Research Organizations, Other End-Users
Subsegments:
1) By Software: Predictive Analytics, Signal Detection, Data Integration, Reporting And Visualization
2) By Hardware: Servers, Storage Devices, Networking Equipment, Sensors, Monitoring Devices
3) By Services: Implementation Services, Maintenance And Support, Consulting Services, Training Services, Data Management Services
Artificial Intelligence (AI)-Driven Medical Device Vigilance Platform Market Transformation Trends: Which Innovations Are Driving Change?
Leading enterprises within the AI-powered medical device vigilance platform sector are concentrating their efforts on creating sophisticated offerings, including post-market device monitoring systems, designed to equip healthcare practitioners and device creators with practical intelligence for enhancing patient well-being and refining device application. These post-market device surveillance platforms serve as mechanisms for monitoring and evaluating the safety and efficacy of medical instruments once they are deployed in clinical environments. As an illustration, in October 2025, Basil Systems, a United States entity specializing in AI-driven platforms, introduced its MedTech Safety Signaling platform. This innovative solution leverages artificial intelligence to facilitate the early identification of potential hazards, thereby redefining post-market device surveillance as a preemptive safety strategy. It adeptly processes a wide array of documentation, encompassing regulatory filings, inspection findings, and narratives detailing adverse incidents, utilizing large language models that have undergone training on an extensive industry-wide dataset to discern subtle patterns often missed through manual analysis. The platform meticulously organizes and interprets this information, establishing connections between related occurrences and their original data sources, accompanied by associated confidence metrics. Consequently, manufacturers gain the capacity to detect emerging safety trends, bolster their preventative strategies, anticipate scrutiny from regulatory bodies, and inform crucial decisions pertaining to product evolution.
Artificial Intelligence (AI)-Driven Medical Device Vigilance Platform Market Major Participants And Competitive Dynamics
Major companies operating in the artificial intelligence (AI)-driven medical device vigilance platform market are Amazon Web Services Inc., Johnson & Johnson Services Inc., International Business Machines Corporation, Oracle Corporation, Abbott Laboratories, Medtronic Plc, Siemens Healthineers AG, Stryker Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Cognizant Technology Solutions Corporation, Boston Scientific Corporation, DXC TECHNOLOGY COMPANY, Baxter International Inc., Wipro Limited, Zimmer Biomet Holdings Inc., Veeva Systems Inc., Medidata Solutions Inc., Tata Consultancy Services Limited, AssurX Inc.
Access The Complete Artificial Intelligence (AI)-Driven Medical Device Vigilance Platform Market Report:
Artificial Intelligence (AI)-Driven Medical Device Vigilance Platform Market Geographic Analysis: Where Is Demand Growing The Fastest?
North Americawas the largest region in the artificial intelligence (AI)-driven medical device vigilance platform market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven medical device vigilance platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
